ANVISA registration

GammaZyme-B

Registration 10154450203. IMUNOHEMATOLOGIA - REAGENTES COMPLEMENTARES

Registration details

Registration number10154450203
Application number25351676765202018
Technical nameIMUNOHEMATOLOGIA - REAGENTES COMPLEMENTARES
Risk classI
Published on23/07/2020
ValidityIndefinite validity

Registration holder

Legal nameFRESENIUS HEMOCARE BRASIL LTDA.
CNPJ49.601.107/0001-84

Manufacturer

  • IMMUCOR, INC ESTADOS UNIDOS DA AMÉRICA

Other registrations held by FRESENIUS HEMOCARE BRASIL LTDA.view all

immuClone Anti-CDE Galileo IgM + IgG

10077090100

MONOCLONAL CONTROL

10077090101

ANALISADOR DE IMUNOHEMATOLOGIA GALILEO ECHO

10077090104

immuClone Anti- Cw Galileo IgM

10077090105

GALILEO NEO

10077090107

FAMÍLIA DE REAGENTES PARA IMUNOHEMATOLOGIA - RH-HR MONOCLONAL

10077090108

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist